ribociclib (kisqali) Report issue

Small molecule Approved FDA First in Class Priority Review FDA
AACT ChEMBL DrugBank Drugs@FDA MeSH PubChem
Back

Drug Pricing Summary

AUS PBS

$66.6284 - $67.9610

VA Big4

$2412.7200 - $3647.2800

VA FSS

$3265.3700 - $4898.0400

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
ribociclib 200 mg (TABLET) $66.6284 AUS PBS generic
  • Kisqali (63)
    		•  Novartis Pharmaceuticals Australia Pty Limited
    ribociclib 200 mg (TABLET) $66.9616 AUS PBS generic
  • Kisqali (42)
    		•  Novartis Pharmaceuticals Australia Pty Limited
    ribociclib 200 mg (TABLET) $67.9610 AUS PBS generic
  • Kisqali (21)
    		•  Novartis Pharmaceuticals Australia Pty Limited
    ribociclib 200 mg (TABLET) $2412.7200 VA Big4
  • KISQALI (3)
    		•  Novartis Pharmaceuticals Corporation
    ribociclib 200 mg (TABLET) $3023.1767 VA Big4
  • KISQALI (3)
    		•  Novartis Pharmaceuticals Corporation
    ribociclib 200 mg (TABLET) $3265.3700 VA FSS
  • KISQALI (3)
    		•  Novartis Pharmaceuticals Corporation
    ribociclib 200 mg (TABLET) $3647.2800 VA Big4
  • KISQALI (1)
    		•  Novartis Pharmaceuticals Corporation
    ribociclib 200 mg (TABLET) $4081.7133 VA FSS
  • KISQALI (3)
    		•  Novartis Pharmaceuticals Corporation
    ribociclib 200 mg (TABLET) $4898.0400 VA FSS
  • KISQALI (1)
    		•  Novartis Pharmaceuticals Corporation

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue